Turkey Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Turkey industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Turkish pharmaceuticals market had total revenues of $7.6 billion in 2022, representing a compound annual growth rate (CAGR) of 1.7% between 2017 and 2022.
- 0
- The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the Turkish Statistical Institute, total health expenditure increased by 41.6% in 2021 compared to the previous year and reached TRY353.9 billion ($39.7 billion).
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Turkey
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Turkey
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Turkey pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Turkey pharmaceuticals market by value in 2022?
- What will be the size of the Turkey pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Turkey pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Turkey's pharmaceuticals market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What has been the rationale behind recent partnerships?
- 8 Company Profiles
- 8.1. Novartis AG
- 8.2. Sanofi SA
- 8.3. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
- 8.4. Pfizer Inc.
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Turkey pharmaceuticals market value: $ billion, 2017-22
- Table 2: Turkey pharmaceuticals market geography segmentation: $ billion, 2022
- Table 3: Turkey pharmaceuticals market value forecast: $ billion, 2022-27
- Table 4: Novartis AG: key facts
- Table 5: Novartis AG: Annual Financial Ratios
- Table 6: Novartis AG: Key Employees
- Table 7: Novartis AG: Key Employees Continued
- Table 8: Sanofi SA: key facts
- Table 9: Sanofi SA: Annual Financial Ratios
- Table 10: Sanofi SA: Key Employees
- Table 11: Sanofi SA: Key Employees Continued
- Table 12: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: key facts
- Table 13: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
- Table 14: Pfizer Inc.: key facts
- Table 15: Pfizer Inc.: Annual Financial Ratios
- Table 16: Pfizer Inc.: Key Employees
- Table 17: Pfizer Inc.: Key Employees Continued
- Table 18: Turkey size of population (million), 2018-22
- Table 19: Turkey gdp (constant 2005 prices, $ billion), 2018-22
- Table 20: Turkey gdp (current prices, $ billion), 2018-22
- Table 21: Turkey inflation, 2018-22
- Table 22: Turkey consumer price index (absolute), 2018-22
- Table 23: Turkey exchange rate, 2018-22
- List of Figures
- Figure 1: Turkey pharmaceuticals market value: $ billion, 2017-22
- Figure 2: Turkey pharmaceuticals market geography segmentation: % share, by value, 2022
- Figure 3: Turkey pharmaceuticals market value forecast: $ billion, 2022-27
- Figure 4: Forces driving competition in the pharmaceuticals market in Turkey, 2022
- Figure 5: Drivers of buyer power in the pharmaceuticals market in Turkey, 2022
- Figure 6: Drivers of supplier power in the pharmaceuticals market in Turkey, 2022
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Turkey, 2022
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Turkey, 2022
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Turkey, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook